Literature DB >> 8821586

Interleukin-13: characterization and biologic properties.

A N McKenzie1, G Zurawski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8821586     DOI: 10.1007/978-1-4613-1241-3_15

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


× No keyword cloud information.
  5 in total

1.  Low expression of the interleukin (IL)-4 receptor alpha chain and reduced signalling via the IL-4 receptor complex in human neonatal B cells.

Authors:  Cuixia Tian; Grace K Kron; Kevin M Dischert; James N Higginbotham; James E Crowe
Journal:  Immunology       Date:  2006-06-08       Impact factor: 7.397

2.  IL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis.

Authors:  Werner Stenzel; Uwe Müller; Gabriele Köhler; Frank L Heppner; Manfred Blessing; Andrew N J McKenzie; Frank Brombacher; Gottfried Alber
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

3.  Intracranial elimination of human glioblastoma brain tumors in nude rats using the bispecific ligand-directed toxin, DTEGF13 and convection enhanced delivery.

Authors:  Seunguk Oh; John R Ohlfest; Deborah A Todhunter; Vincent D Vallera; Walter A Hall; Hua Chen; Daniel A Vallera
Journal:  J Neurooncol       Date:  2009-06-11       Impact factor: 4.130

4.  Distinct roles for IL-13 and IL-4 via IL-13 receptor alpha1 and the type II IL-4 receptor in asthma pathogenesis.

Authors:  A Munitz; E B Brandt; M Mingler; F D Finkelman; M E Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-14       Impact factor: 11.205

5.  Anti-glioblastoma effect of a recombinant bispecific cytotoxin cotargeting human IL-13 and EGF receptors in a mouse xenograft model.

Authors:  Brad J Stish; Seunguk Oh; Daniel A Vallera
Journal:  J Neurooncol       Date:  2007-12-15       Impact factor: 4.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.